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During endoplasmic reticulum (ER) stress, homeo-
static signaling through the unfolded protein
response (UPR) augments ER protein-folding capa-
city. If homeostasis is not restored, the UPR triggers
apoptosis. We found that the ER transmembrane
kinase/endoribonuclease (RNase) IRE1a is a key
component of this apoptotic switch. ER stress
induces IRE1a kinase autophosphorylation, acti-
vating the RNase to splice XBP1 mRNA and produce
the homeostatic transcription factor XBP1s. Under
ER stress—or forced autophosphorylation—IRE1a’s
RNase also causes endonucleolytic decay of many
ER-localized mRNAs, including those encoding
chaperones, asearly events culminating in apoptosis.
Using chemical genetics, we show that kinase inhibi-
tors bypass autophosphorylation to activate the
RNase by an alternate mode that enforces XBP1
splicing and averts mRNA decay and apoptosis.
Alternate RNase activation by kinase-inhibited IRE1a
can be reconstituted in vitro. We propose that diver-
gent cell fates during ER stress hinge on a balance
between IRE1a RNase outputs that can be tilted
with kinase inhibitors to favor survival.
INTRODUCTION
Chaperones and other enzymatic activities residing in the endo-
plasmic reticulum (ER) promote folding of secretory proteins.
Demand on ER protein folding often outpaces capacity, causing
unfolded proteins to accumulate. During these instances of ER
stress, intracellular signaling pathways termed the unfolded
protein response (UPR) become active. Mammalian cells contain
three unfolded protein sensors—IRE1a, PERK, and ATF6—that562 Cell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc.initiate UPR activation. Signaling by these sensors upregulates
transcription of genes encoding ER chaperones, oxidoreduc-
tases, and ER-associated degradation (ERAD) components
(Travers et al., 2000). The UPR also exerts a translational block
during ER stress (Harding et al., 2001). These outputs are adap-
tive because they reduce ER protein load, augment ER protein
folding capacity, and promote degradation of unfolded proteins
(Ron and Walter, 2007). If ER stress is successfully reduced,
negative feedback causes UPR signaling to wane as homeo-
stasis becomes restored (Merksamer et al., 2008).
Failure to adapt to ER stress causes the UPR to trigger
apoptosis. Chemicals that inhibit ER protein glycosylation or
deplete ER calcium can be used to impose ER stress at unreme-
diable levels, deterministically triggering apoptosis. Also, muta-
tions in many genes encoding secretory proteins cause these
proteins to fold improperly, thereby generating chronic ER stress
and leading to cell-degenerative diseases. For example, unoxi-
dizable proinsulin mutants cause rare forms of diabetes in hu-
mans and rodents (Oyadomari et al., 2002; Stoy et al., 2007).
Removal of ER-stressed cells through UPR-mediated apoptosis
may occur physiologically, but widespread apoptosis becomes
pathological when it leads to the loss of large numbers of cells
in vital organs (Kaufman, 2002).
Paradoxically, UPR signaling promotes opposite cell fates—
adaptation/survival versus death—thereby acting as a switch.
Underlying mechanisms of this switching process remain
unclear. Because UPR signaling exhibits heavy crosstalk, indi-
vidual signaling events are unlikely to completely determine
cell fate. However, it is reasonable to expect that the three
unfolded protein sensors—IRE1a, PERK, and ATF6—influence
the life-death decision. Inability of UPR outputs to restore
homeostasis may generate continuous signaling from these
sensors, tipping the balance in favor of apoptosis. To explore
this possibility, we studied the most ancient ER unfolded protein
sensor, IRE1a.
IRE1a is an ER transmembrane protein containing two enzy-
matic activities, a kinase and an endoribonuclease (RNase),
both residing on its cytosolic face (Wang et al., 1998). IRE1a
senses ER unfolded proteins through an ER lumenal domain
that becomes oligomerized during ER stress (Aragon et al.,
2009; Credle et al., 2005; Zhou et al., 2006). Oligomerization
juxtaposes the kinase domains, which consequently trans-
autophosphorylate. Autophosphorylation activates the RNase
activity to cleave XBP1 mRNA at specific sites to excise an intron.
Religation of IRE1a-cleaved XBP1 mRNA shifts the open reading
frame; translation of spliced XBP1 mRNA produces a potent
transcription factor called XBP1s (s indicates spliced) (Calfon
et al., 2002; Yoshida et al., 2001). XBP1s’s target genes encode
protein products that enhance ER protein folding capacity and
quality control (Lee et al., 2003). Thus, IRE1a promotes adapta-
tion via XBP1s.
IRE1a may have functions independent of XBP1 mRNA
splicing. IRE1 was implicated in the decay of ER-localized
mRNAs in D. melanogaster (Hollien and Weissman, 2006).
However, it remains unclear whether ER-localized mRNA decay
occurs in mammalian cells, IRE1a’s RNase directly mediates
such mRNA decay, and the physiological consequences of
mRNA decay are adaptive or destructive. IRE1a was also linked
to proapoptotic c-Jun kinase (JNK) signaling (Urano et al., 2000).
Together, existing data support direct and indirect roles for
IRE1a in both adaptive and destructive processes, but mecha-
nistic details remain unclear.
Kinase activation in signal transduction pathways is often tran-
sitory if downstream effects restore homeostasis. We hypothe-
sized that persistent activation of IRE1a’s kinase could signal
an inability to adapt to ER stress and trigger a switch into
apoptosis. To test this hypothesis, we employed small mole-
cules to forcibly activate IRE1a and key mutants, allowing us
to assign physiological functions to the catalytic activities. We
learned that alternate outputs from IRE1a’s RNase activity
govern opposing cell fate outcomes during ER stress and that
these outputs can be modulated with inhibitors targeting the
kinase domain.
RESULTS
IRE1a RNase Activity Can Be Controlled
through Two Distinct Routes
We began studies on UPR-mediated apoptosis using INS-1 insu-
linoma cells, which are differentiated insulin-producing cells
derived from pancreatic islet b cells. In INS-1 cells undergoing
ER stress from exposure to the ER calcium pump inhibitor thap-
sigargin (Tg), IRE1a autophosphorylates and splices XBP1
mRNA. Both IRE1a-catalyzed events persist throughout Tg treat-
ment as cells undergo apoptosis (Figure S1 available online). To
inquire whether IRE1a activation affects cell fate, we designed
tools to forcibly trigger its two catalytic activities—together or
separately—without imposing upstream ER stress.
Unfolded proteins in the ER promote oligomerization of
IRE1a’s ER lumenal domains as the initial activating event, but
oligomerization can also be driven through mass action (Shamu
and Walter, 1996). We reasoned that by acute elevation of levels
of IRE1a, its ER lumenal domains should spontaneously oligo-
merize, juxtaposing the kinase domains to autophosphorylate
and activate the RNase. To this end, we introduced tetracy-cline-inducible expression constructs driving wild-type (WT)
IRE1a, or various mutants, into INS-1 cells that stably express
Tet repressor (Figures 1A and S2) (Thomas et al., 2004). All
expression constructs were stably integrated at the same chro-
mosomal FRT docking site so as to cancel out position effects
and reliably ascribe differences in downstream physiological
effects to the IRE1a variants. To ensure that physiological effects
of IRE1a signaling are general, and not cell-type specific, we
repeated the strategy using another cell line, T-REx 293.
In these systems, transgenic WT IRE1a is tightly inducible with
doxycyline (Dox) (Figure 1B, lanes 1 and 2). Induced WT IRE1a
proteins become properly ER targeted, and spontaneously auto-
phosphorylate as they accumulate (Figures 1C and 1D). Auto-
phosphorylation activates the RNase, which converts essentially
all cellular XBP1 mRNA to the spliced form (96% ± 3%)
(Figure 2A, lanes 1 and 2).
We then added a second layer of conditionality to test effects
of IRE1a kinase inhibition. We mutated IRE1a at Ile642 to either
Ala or Gly to create enlarged kinase pockets (Figure 1A). I642A
and I642G mutants are severely compromised for autophosphor-
ylation in vitro, indistinguishably so from the kinase-dead
mutant K599A (Figure 1F, lanes 1, 3, 5, and 7) (Tirasophon
et al., 1998). IRE1a (I642A) retains partial XBP1 mRNA splicing
upon induction (57% ± 9% splicing), but IRE1a (I642G) is
completely crippled for splicing (Figure 2A, lanes 5, 6, 9, and
10). IRE1a (I642G) accumulates to levels comparable to trans-
genic WT IRE1a and localizes properly to the ER but does not
autophosphorylate (Figure 1B, lanes 2 and 6, Figure 1C, and
Figure 1D, lanes 5 and 6).
Due to their enlarged kinase pockets, I642A and I642G selec-
tively bind 1NM-PP1, a cell-permeable adenosine nucleotide
mimic with a bulky chemical head group (Figure 1A) (Shah
et al., 1997). As 1NM-PP1 cannot bind the WT IRE1a kinase
domain, autophosphorylation and RNase activity are not
affected (Figure 1F, lanes 1 and 2, and Figure 2A, lanes 2
and 4). However, for both I642 mutants, 1NM-PP1 completely
corrects the defect in XBP1 mRNA splicing (Figure 2A, lanes 2,
6, 8, 10, and 12).
IRE1a (I642A) and IRE1a (I642G) behave as pseudokinases,
a class of kinases that lost phosphotransfer activity through
evolution and instead regulate functions in attached domains
(Boudeau et al., 2006). 1NM-PP1 does not restore autophosphor-
ylation to these mutants (Figure 1F, lanes 4 and 6), but instead
allosterically activates the attached RNase through binding the
pseudokinase.
IRE1a (I642G) was utilized henceforth because of its large
dynamic range: 1.8% ± 0.5% splicing at baseline, to 97.6% ±
2.5% when saturated with 1NM-PP1 (Figure 2A, lanes 10 and
12). 1NM-PP1 activation of splicing by IRE1a (I642G) is finely
tunable, exhibiting an EC50 of 887 nM and a Hill coefficient of
1.86 (Figures 2B and 2C). 1NM-PP1 stimulates splicing in cis:
when IRE1a (I642G) is combined with the RNase active site muta-
tion, K907A (Figure 1A) (Tirasophon et al., 1998), splicing
becomes unresponsive to 1NM-PP1 (Figure 2A, lanes 12 and 16).
Thus, by using Dox to induce expression of either WT IRE1a or
IRE1a (I642G), and also adding 1NM-PP1, which only activates
IRE1a (I642G), we can forcibly trigger XBP1 mRNA splicing
and sustain it for many hours (Figures 2D and 2F). DependingCell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc. 563
Figure 1. Conditional Tools to Forcibly Trigger IRE1a Catalytic Activities
(A) IRE1a mutants in this study and chemical structure of 1NM-PP1.
(B) Anti-Myc immunoblot of IRE1a transgenic proteins induced in INS-1 stable lines with doxycycline (Dox).
(C) Confocal fluorescence micrographs of INS-1 cells showing colocalization of eGFP-WT IRE1a and eGFP-IRE1a (I642G) with transiently transfected
ER-DsRED. Time course immunoblots of transgenic IRE1a proteins induced with Dox in INS-1 cells (anti-Myc and anti-phospho IRE1a).
(D) Anti-total and anti-phospho IRE1a immunoblots of WT IRE1a, I642G, and K907A proteins produced from constructs transfected into Ire1a/ MEFs,
±1NM-PP1.
(E) Immunoprecipitation (IP) of Myc-tagged IRE1a proteins from T-REx 293 cells.
(F) In vitro autophosphorylation of IPed Myc-tagged IRE1a and mutants, ±1NM-PP1.on the cell line we use—those expressing WT IRE1a or IRE1a
(I642G)—the two different activation modes are referred to
as phosphotransfer activation or pseudokinase activation,
respectively. Both modes trigger XBP1 mRNA splicing with
similar kinetics, causing XBP1s protein to accumulate to levels
mimicking those that occur during ER stress (Figures 2E and
2G). However, neither activation mode causes ER stress per
se, as evidenced by lack of eIF2a phosphorylation over 8 hr
(Figure S3).564 Cell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc.Cell Fate Is Determined by Distinct Mechanisms
of IRE1a RNase Activation
By forcibly activating IRE1a through two different modes without
relying on pleiotropic ER stress agents that trigger all three
UPR arms, we could dissect effects of IRE1a’s catalytic
activities on cell fate. We find that phosphotransfer activation
triggers apoptosis in INS-1 cells starting at 36 hr (Figures 3A
and 3B). In contrast, pseudokinase-activated INS-1 cells do
not undergo apoptosis. These divergent fates are replicated in
phosphotransfer- and pseudokinase-activated T-REx 293 cells,
indicating that they are general (Figure S5, Movies S1–S4).
Because both activation modes cause complete XBP1 mRNA
splicing to produce equivalent amounts of XBP1s, the divergent
fates of survival versus death cannot be ascribed to outputs of
this transcription factor. Indeed, conditional expression of
XBP1s is itself not proapoptotic (Figures 3A and 3B), suggesting
instead that phosphotransfer-activated IRE1a transmits pro-
apoptotic signals independent of XBP1 mRNA splicing.
A plausible explanation holds that proapoptotic outputs of WT
IRE1a proceed directly from phosphotransfer activity, which
IRE1a (I642G) lacks. If true, one would predict that kinase-
active/RNase-dead IRE1a mutants should be as cytotoxic as
WT IRE1a, if not more so, since the adaptive benefits derived
from XBP1s would also be lost. To test this notion, we condition-
ally expressed two different kinase-active/RNase-dead mutants,
K907A and N906A, in INS-1 cells. Surprisingly, despite retaining
full phosphotransfer activity (Figure 1F, lanes 1 and 9, and
Figure S6), K907A and N906A do not induce apoptosis (Figures
3A and 3B).
Endogenous IRE1a is also proapoptotic during unremediable
ER stress: Ire1/ mouse embryonic fibroblasts (MEFs) demon-
strate greater survival than Ire1+/+ MEFs under toxic doses of
various ER stress agents (Figure 3C). In Ire1/ MEFs, apoptosis
is spontaneously triggered through transient expression of WT
IRE1a, but not through the I642G, K907A, or N906A mutants
(Figure 3D). Similarly, apoptosis is triggered when WT IRE1a
(but no other mutant) is expressed in Xbp1/ MEFs, strength-
ening the notion that XBP1s is unnecessary for IRE1a-mediated
apoptosis (Figure 3D). WT IRE1a triggers mitochondrial (intrinsic)
apoptosis because it requires Bax and Bak genes (Figure 3E)
(Wei et al., 2001).
Our results clearly argue that apoptotic signals from WT IRE1a
require an active RNase. Yet pseudokinase activation of the
same RNase through 1NM-PP1 does not trigger apoptosis.
Furthermore, pretreatment of cells through pseudokinase
activation reduces apoptosis when cells are exposed to Tm
(Figure 3F). Cytoprotection requires three components—a cata-
lytically active RNase in IRE1a (I642G), the XBP1 gene, and
1NM-PP1—indicating that it proceeds from a preconditioned
state brought about through pre-emptive XBP1s production.
These paradoxical results clearly focus attention on the RNase
activity as the immediate downstream effector of both life and
death outputs emanating from IRE1a. To reconcile these find-
ings, we hypothesized that for IRE1a, the specific kinase activa-
tion mode—phosphotransfer versus pseudokinase—must exert
two mechanistically distinct outputs from the RNase that cause
opposite effects on cell fate. To illuminate the mechanistic basis
of these alternate RNase outputs, we employed gene expression
profiling.
Phosphotransfer Activation of IRE1a RNase Causes
ER-Localized mRNA Decay
Using DNA microarrays, we compared cellular mRNAs in phos-
photransfer- and pseudokinase-activated T-REx cells at two
time points: an early time point of 8 hr, when induction of trans-
genic IRE1a proteins (and autophosphorylation) and XBP1
splicing have all reached new steady-state levels, and a latertime point of 24 hr, when divergent cell fate outcomes start to
emerge between the two activation modes.
Pairwise expression profiling was conducted using untreated
cells as controls. Clustering analysis indicates excellent overlap
of genes induced more than 2-fold between both activation
schemes, especially at 24 hr (Figure 4A). The induced genes
have been previously implicated in secretory processes of
protein translocation (Travers et al., 2000), ER-to-Golgi traf-
ficking and retrieval (Higashio and Kohno, 2002), and ER protein
folding (Table S1).
However, when comparing genes whose expression is signif-
icantly reduced by at least 2-fold, large differences are found
between the two activation modes. By 8 hr, the expression levels
of 200 different mRNAs are reduced under phosphotransfer acti-
vation, but not under pseudokinase activation (Figure 4B) (Table
S2). Reduction of these mRNAs is evident as early as 4 hr after
phosphotransfer activation, and levels continue to decline over
several hours (Figure S5A). By contrast, XBP1 mRNA splicing
is already maximal by 4 hr. Reduction of these mRNAs precedes
entry of phosphotransfer-activated cells into apoptosis by many
hours, indicating that it is not a consequence of cell death
(Figures 3A, 3B, and S5 and Movies S1–S4). The pattern of
mRNA reduction is general, as it also occurs in phosphotrans-
fer-activated INS-1 cells (Figure 4C). mRNA reduction does not
occur under pseudokinase-activation, upon expression of
kinase-active/RNase-dead mutant (N906A), or upon expression
of XBP1s (Figure 4C).
Using annotation databases, we find that genes encoding
secretory pathway proteins are strongly enriched in the sets dis-
playing reduced expression (see annotation key in Figures 4B
and 4C, and Tables S2 and S3 for statistics). mRNAs of these
genes are predicted to be localized near the ER membrane during
translocational translation of their protein products, in close prox-
imity to IRE1a, which could promote their endonucleolytic decay.
Inability of the kinase-active/RNase-dead mutant (N906A) to
cause decay of these mRNAs is consistent with the notion that
the IRE1a RNase catalytic activity is directly responsible for
promoting the mRNA decay in vivo.
The profile of ER-localized mRNA decay under IRE1a phos-
photransfer activation is mimicked in cells undergoing ER stress.
Three examples follow: First, a time course of parent INS-1 CAT
cells treated with Tg shows ER mRNA decay evolving over time
(Figure 4D and Table S4). Second, Ire1a/ MEFs treated with Tg
show significantly reduced ER mRNA decay as compared to
Ire1a+/+ MEFs, indicating dependence of decay on endogenous
IRE1a (Figure 4E and Table S5). Third, pancreatic b-derived cells
carrying a mutation in the insulin-encoding gene, Ins2(C96Y),
display significant reductions in ER-localized mRNAs even
during normal growth when compared to isogenic WT cells
(Figure 4F and Table S6). These so-called ‘‘Akita’’ variants
prevent ER oxidative folding of the encoded proinsulin and cause
chronic ER stress in b cells and diabetes in mice (Oyadomari
et al., 2002).
Many hundreds of the decaying mRNAs encode proteins that
transit through the ER en route to the cell surface, intracellular
organelles, or the cell exterior. These secretory pathway cargo
proteins—‘‘SPC’’—include insulin, HMG-CoA reductase, b2
microglobulin, and numerous cell surface receptors (TablesCell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc. 565
Figure 2. Two Distinct Modes to Produce XBP1s Transcription Factor
(A) EtBr-stained agarose gel of XBP1 complementary DNA (cDNA) amplicons after induction of IRE1a variants for 8 hr, followed by 5 mM 1NM-PP1 (or dimethyl
sulfoxide [DMSO]) for 4 hr. The cDNA amplicon of unspliced XBP1 mRNA is cleaved by a PstI site within a 26 nt intron to give 2U and 3U. IRE1a-mediated cleavage
of the intron and religation in vivo removes the PstI site to give the 1S (spliced) amplicon. * indicates a spliced/unspliced XBP1 hybrid amplicon. The ratio of spliced
over (spliced + unspliced) amplicons—1S/(1S+2U+3U)—is reported as ‘‘% spliced XBP1 amplicons’’ in histograms. Three independent biological samples were
used. Data are shown as mean ±SD. **p < 0.01 and ***p < 0.002. ns, not significant.566 Cell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc.
S2–S6). We validated that IRE1a phosphotransfer activation
is sufficient to cause decay of insulin (Ins1) mRNA decay
(Figure 5A), and an ER-targeted but not a cytosolic-targeted
GFP mRNA (Figure S14). Phosphotransfer activation causes
insulin mRNA to decay rapidly, as was also shown to occur
during ER stress (Lipson et al., 2008); insulin mRNA decay
precedes large reductions in proinsulin protein (Figures 5A, 5B,
and S7). In contrast, pseudokinase activation, or expression of
the N906A mutant, preserves both insulin mRNA and proinsulin
levels (Figures 5A and 5B). Small interfering RNA (siRNA) knock-
down of endogenous IRE1a in INS-1 parent cells increases Ins1
mRNA levels during ER stress, confirming that IRE1a is neces-
sary for Ins1 mRNA decay (Figures 5E and S12).
The mRNAs that we find decaying under phosphotransfer
activation or under ER stress encode not only secretory cargo
proteins, but also many ER and downstream secretory organ-
elle-resident activities. These are annotated as ‘‘SPR’’ for secre-
tory pathway resident (Figures 4B–4F). Validation of four such
targets is shown in Figure 5C: mRNAs encoding Golgi-localized
glycosylating enzymes Galnt2 and Gyltl1b, ER-localized cocha-
perone Pdia4, and the ER membrane structural protein Rtn4.
Because many of these mRNAs are replenished by UPR-medi-
ated transcription, competition through IRE1a-mediated decay
may determine their steady-state levels. Therefore, downregu-
lation of many UPR targets may have even evaded detection
in arrays. To identify representative targets, we inhibited tran-
scription with Actinomycin D (ActD) before adding Tg, and we
found that mRNAs encoding the abundant ER chaperone BiP,
as well as Gyltl1b, decay more rapidly during ER stress
(Figure 5D). Remarkably, BiP mRNA decay depends on IRE1a
because reduction of endogenous IRE1a through RNA interfer-
ence (RNAi) increases BiP mRNA levels during ER stress
(Figure 5E).
Basal splicing of XBP1 mRNA in normally growing Akita
cells is 42%—twice the level of isogenic WT counterparts
(ct14 cells) (Figure 5F). This increased baseline in IRE1a
activity correlates with significantly decreased steady-state
levels of many ER-localized mRNAs in the Akita cells
(Figure 4F). Akita cells have lower insulin mRNA and proinsulin
protein content than ct14. While the Akita mutation is in the
Ins2 gene, Ins1 mRNA is also reduced, implying a trans-domi-
nant effect. Akita cells have significantly decreased levels of
many UPR target mRNAs and their protein products, such
as ERdj5, and exhibit a 3-fold higher spontaneous apoptosis
rate than ct14 (Figure 5F).
We investigated whether we could uncouple endogenous
IRE1a’s XBP1 splicing activity from its mRNA decay activity by
varying the degree of ER stress with Tg. Cells cultured in low
(5 nM) Tg underwent mild XBP1 splicing (26%), proliferatedslightly better than untreated cells, and accumulated Ins1 and
BiP mRNAs over 24 hr (Figure S8). However, cells treated with
higher Tg (10 nM) had larger increases in XBP1 mRNA splicing
(40%) and IRE1a autophosphorylation, and they displayed drop-
offs in Ins1 mRNA, and in BiP mRNA after an initial period during
which BiP mRNA climbed 3.5-fold. These cells stopped prolifer-
ating and underwent apoptosis, indicating that they may have
crossed a threshold of unremediable ER stress. These results
argue that under low ER stress conditions, IRE1a preferentially
splices XBP1, while at higher stress it also causes ER-localized
mRNA decay.
Time courses confirm that protein products encoded by
many decaying mRNAs decline under ER stress. Figure S9
shows decaying IGFBP1, site 1 and 2 proteases (needed to
activate ATF6), BiP, and ERdj5 proteins. Taken together, our
data show that under conditions of either overwhelming ER
stress induction (e.g., 1 mM Tg) or chronic low-level stress
(expression of Akita insulin or 10 nM Tg), mRNAs encoding
ER-resident activities such as chaperones start to decay, as
also occurs during phosphotransfer activation. Decay of ER-
resident activities under phosphotransfer activation
(Figure S10) may result in increased ER stress. Consistent
with this notion, phosphorylation of eIF2a (Figure S10) and
c-Jun kinases (JNK) (Figure S11) increases at late time points,
as also occurs under ER stress. Reciprocally, chaperone
levels rise under pseudokinase activation, and baseline levels
of phospho-eIF2a and phospho-JNK decline, providing
a mechanistic explanation for how 1NM-PP1 could enhance
ER functions and precondition cells to resist apoptosis during
ER stress.
Kinase Inhibitors Constrain IRE1a to Cleave XBP1
and Spare Insulin mRNA
We show that IRE1a has two functions in vivo, both requiring its
RNase: (1) IRE1a initiates XBP1 mRNA splicing through site-
specific cleavage, and (2) is necessary and sufficient for ER-local-
ized mRNA decay. To determine whether the second function
proceeds directly from endonucleolytic activity, we reconstituted
cleavage against XBP1 and mouse Ins2 RNAs in a cell-free
system. We immunoprecipitated three versions of IRE1a: WT,
N906A, and I642G, and incubated equivalent protein amounts
with in vitro transcribed Ins2 and XBP1 RNA. WT IRE1a cleaves
XBP1 RNA at previously identified sites in two loops flanking
the intron (Figure 6A) (Calfon et al., 2002). We find that WT
IRE1a also cleaves mouse Ins2 RNA in vitro (Figure 6A). Several
specific Ins2 RNA cleavage sites are identified that are highly
reproducible using WT IRE1a proteins isolated on different occa-
sions. Rat Ins1 RNA was similarly cleaved at specific sites
(Figure S13). We mapped the cleavage sites on IRE1a-treated(B) Percent spliced XBP1 amplicons in IRE1a (I642G)-expressing INS-1 cells as a function of [1NM-PP1].
(C) Curve fitting to triplicate 1NM-PP1 concentration-dependent splicing assays in IRE1a (I642G)-expressing T-REx 293 cells.
(D) Time course of XBP1 mRNA splicing under ‘‘phosphotransfer activation’’—defined as provision of Dox (0.1 mg/ml) and 1NM-PP1 (5 mM) to stable WT IRE1a-
expressing cells. 1NM-PP1 is inert for WT IRE1a—(A), lane 3—but always added to maintain consistency with pseudokinase activation.
(E) ER stress-mediated splicing of XBP1 mRNA in INS-1 CAT cells with tunicamycin—Tm—(5 mg/ml) for 2 hr.
(F) Time course of XBP1 mRNA splicing under ‘‘pseudokinase activation,’’ defined as provision of Dox (0.1 mg/ml) and 1NM-PP1 (5 mM) to stable IRE1a (I642G)-
expressing cells. Time courses shown used T-REx 293 cells and were identical in INS-1 cells (data not shown).
(G) Immunoblot of XBP1s transcription factor under phosphotransfer or pseudokinase activation in INS-1 cells, and INS-1 CAT cells under Tm.Cell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc. 567
Figure 3. Divergent Cell Fates under Phosphotransfer and Pseudokinase Activation of IRE1a RNase
INS-1 cells under phosphotransfer or pseudokinase activation, activation of kinase-active/RNase-dead mutants K907A and N906A, and expression of XBP1s.
(A) Time course of percent cells staining positive for Annexin V.
(B) Time course immunoblots of full-length and cleaved caspase 3, and Myc-IRE1a and XBP1s proteins. NT, not treated.
(C) Percent Ire1a/ and Ire1a+/+ MEFs staining positive for Annexin V during ER stress induced by brefeldin A (BFA) (0.5 mg/mL), Tm (0.5 mg/mL), or Tg (0.1 mM).
(D) Percent of cells staining positive for Annexin V 24 hr after transfection of expression vectors encoding WT IRE1a, I642G, K907A, or N906A into Ire1a/ or
Xbp1/ MEFs. Five micromolar 1NM-PP1 (or DMSO) was added at the time of transfection.
(E) Percent of cells staining positive for Annexin V 24 hr after transfection of WT IRE1a expression vector (WT) or empty vector (vector) in Bax+/+ Bak+/+ or Bax/
Bak/ MEFs.
(F) Percent of cells staining positive for Annexin V 24 hr after provision of varying concentrations of Tm in Ire1a/ orXbp1/ MEFs. All cells were previously trans-
fected with 1 mg of expression vectors bearing I642G or I642G/K907A for 8 hr, treated with 1NM-PP1 (or DMSO) overnight, and then treated for 24 hr with Tm.
Data are shown as mean ±SD. **p < 0.02 and ***p < 0.002. Figure S3 shows equivalent transgenic IRE1a protein levels. For all experiments, three independent
biological samples were measured.568 Cell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc.
Ins1 and Ins2 RNA products by primer extension and found
sequence similarity to the scission site in XBP1 RNA (Figure 6D).
IRE1a (N906A) cannot cleave either RNA, arguing against the
possibility that RNases copurifying with phosphorylated IRE1a
proteins nonspecifically degraded Ins1 and Ins2 RNA (Figures
6B and S13). IRE1a (I642G) proteins can cleave XBP1 RNA
in vitro, but only under 1NM-PP1 (Figure 6A). Using an internally
FRET-quenched XBP1 RNA substrate, 1NM-PP1 activated
IRE1a (I642G) is also able to cleave even a single XBP1 RNA
stem-loop, similar to the WT (Figure 6C). However, IRE1a
(I642G) spares Ins2 and Ins1 RNA, even under 1NM-PP1 (Figures
6A and S13), as it does in vivo. Thus, for IRE1a (I642G), 1NM-PP1
uncouples endonucleolytic cleavage of XBP1 RNA from cleavage
of insulin RNAs.
To identify kinase inhibitors that similarly activate WT IRE1a
RNase, we implemented a screening campaign using the
FRET-quenched XBP1 RNA substrate (Figure 6C) in a high-
throughput format (D.H., B.J.B., and F.R.P., unpublished data).
Several small molecule activators of murine IRE1a, including
5-methyl-1H-pyrazol-3-yl-2-phenylquinazolin-4-yl amine (H6)
and anticancer drugs imatinib and sunitinib (Figure S15A), were
identified along with another compound called APY29, recently
reported along with sunitinib to activate yeast IRE1 (Korennykh
et al., 2009). All these compounds inhibit murine WT IRE1a
trans-autophosphorylation in vitro to varying degrees (APY29 >
sunitinib > H6 > imatinib). In INS-1 cells, APY29 and H6 increase
XBP1 splicing in the absence of ER stress. Moreover, all these
compounds allow XBP1 mRNA splicing to proceed fully under
ER stress. Under Tg-induced ER stress, APY29 strikingly rescues
decline of Ins2 mRNA in a dose-responsive manner, and H6 and
imatinib have similar (albeit modest) effects. These results
suggest that kinase inhibitors may uncouple the two endonucleo-
lytic output modes of WT IRE1a, just as 1NM-PP1 does when
acting on the I642G mutant.
DISCUSSION
Mechanistic Basis of Binary Signaling
through IRE1a during ER Stress
Our findings focus on apoptotic outputs of IRE1a that have
received little attention to date. Classically, IRE1a is considered
a homeostat in the UPR. Here, we found that apart from these
adaptive roles, IRE1a is also a potent executioner. Thus IRE1a
outputs are ‘‘double edged.’’ Binary outputs are consistent
with those expected of a signaling switch, and IRE1a’s divergent
signaling may be an important component in the UPR’s homeo-
static-apoptotic switching network.
We traced divergent signaling by IRE1a to alternate outputs
of its RNase. The adaptive role played by the RNase is well
understood: by splicing XBP1 mRNA, it produces the cytopro-
tective XBP1s transcription factor. IRE1a also displays proa-
poptotic signaling (Urano et al., 2000), yet underlying mecha-
nisms are unclear. It was previously reported that IRE1 is
needed in D. melanogaster to mediate rapid decay of ER-local-
ized mRNAs (Hollien and Weissman, 2006). Here, we showed
for the first time that ER-localized mRNA decay also occurs in
many mammalian cells undergoing ER stress. Early in the
UPR, such decay may provide some immediate respite byreducing protein translocational load. This resembles early
outputs of PERK kinase, which temporarily suppresses transla-
tion under ER stress. If these rapid measures succeed, reduc-
tion of unfolded proteins should cause UPR signaling to decay
as homeostasis becomes restored. XBP1s downstream effects
may take longer to manifest since they require de novo protein
synthesis; these outputs may help precondition the ER to
combat future ER stress.
Alternatively, under unremediably high levels of ER stress,
sustained increases in XBP1 mRNA splicing are accompanied
by decay in many ER-localized mRNAs. These mRNAs encode
secretory cargo proteins, and secretory pathway-resident activ-
ities that promote folding of cargo. Continued decay of these
mRNAs under unmitigated ER stress may deplete crucial cell-
surface signaling proteins and, perhaps more importantly, may
destabilize ER protein folding as ER-resident protein folding
activities become reduced.
Without relying on pleiotropic ER stress-promoting agents that
activate all three proximal arms of the UPR simultaneously, our
tools allow us to link ER-localized mRNA decay directly to the
IRE1a RNase. Since IRE1a activation occurs through self-asso-
ciation of its lumenal domains under ER stress, we simulated this
regulated event through a step increase in transgenic IRE1a
proteins. Driven from the same locus in isogenic cell lines, equiv-
alent dynamic increases occurred for all IRE1a mutants; thus,
divergent physiological effects are directly traceable to the
varying alleles. Using these tools, we found that phosphotransfer
activation is the only mode that suffices to trigger ER-localized
mRNA decay and that IRE1a must contain a catalytically active
RNase to cause decay.
Several lines of evidence argue that IRE1a-mediated ER
mRNA decay is not confined to situations of controlled overex-
pression. ER-localized mRNA decay during ER stress is reduced
when the Ire1a gene is deleted or the protein reduced through
RNAi. Therefore, IRE1a is both necessary and sufficient for ER
mRNA decay under stress. Finally, using cell-free systems, we
identified insulin RNA as the first direct extra-XBP1 endonucleo-
lytic substrate for IRE1a. We predict that many of the hundreds
of decaying mRNAs we identified may also be direct IRE1a
endonucleolytic substrates.
In all of our experiments, ER mRNA decay correlated positively
with apoptosis. A parsimonious interpretation holds that IRE1a-
mediated ER mRNA decay contributes to apoptosis by reducing
secretory pathway-resident activities that mediate protein
folding, and perhaps important cargo substrates, to insufficiently
low levels. Downstream JNK phosphorylation also becomes trig-
gered under phosphotransfer activation of the IRE1a RNase, as
it does under ER stress (Figures S11A–S11C)—this may serve to
amplify proapoptotic signaling. Thus, beyond some threshold of
ER stress, IRE1a outputs may morph from homeostatic feed-
back loops (XBP1s driven), into positive feedback proapoptotic
loops, ushering in a terminal UPR that actively drives cells toward
apoptosis.
IRE1a-triggered ER mRNA decay may have previously gone
unnoticed in mammalian cells because it causes cell death. In
our experience, constitutive overproduction of WT IRE1a in
stable lines eventually fails, since surviving cells invariably lose
or silence the transgene (data not shown). Therefore, tightCell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc. 569
Figure 4. Gene Expression Profiling Reveals ER-localized mRNA Decay under IRE1a Phosphotransfer Activation and ER Stress
Hierarchical clustering analysis of gene expression changes from DNA microarrays.
(A) Genes whose expression is 2-fold or more increased under either phosphotransfer activation or pseudokinase activation in T-REx 293 cells.
(B) Genes whose expression is significantly reduced 2-fold or more at 8 hr in phosphotransfer-activated T-REx 293 cells (versus untreated) (q value < 0.05) and
significantly different between phosphotransfer activation and pseudokinase activation at 8 hr (q value < 0.05).
(C) Genes whose expression is significantly reduced 2-fold or more at 24 hr in phosphotransfer-activated INS-1 cells (versus untreated) (q value < 0.05) and
significantly different between phosphotransfer activation, pseudokinase activation, and phosphotransfer activation of the RNase-dead mutant N906A at
24 hr (q value < 0.05). Expression changes for these genes at 8 and 16 hr under phosphotransfer activation and at 24 hr in XBP1s-expressing cells are displayed
in the same row.570 Cell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc.
conditional systems to produce IRE1a upon demand are neces-
sary to prevent adaptation. Recent reports that IRE1a solely
promotes cytoprotection utilized lines constitutively overpro-
ducing only kinase-dead IRE1a (Lin et al., 2007; Lin et al.,
2009). Without kinase-active controls, those studies concluded
that IRE1a outputs are always adaptive, in contrast to what we
found.
Model of How Kinase Inhibitors Suppress IRE1a-
Mediated ER mRNA Decay
We were excited to find that kinase inhibitors can modulate
IRE1a’s divergent RNase outputs. This was first revealed using
1NM-PP1-sensitized IRE1a as proof of concept. 1NM-PP1 forc-
ibly activates XBP1 mRNA splicing by I642G in cis. This pharma-
cological maneuver produces XBP1s in the absence of ER
stress, without simultaneously causing decay of ER mRNAs.
Preconditioning through XBP1s targets may help cells resist
apoptosis when ER stress is subsequently encountered.
How are XBP1 mRNA splicing and ER-localized mRNA
destruction separable in IRE1a (I642G), but not in the WT?
We propose a model: When IRE1a (I642G) is overproduced, its
lumenal domains spontaneously oligomerize in the ER
membrane. This juxtaposes the cytosolic kinases, but because
the space-creating I642G substitution in the kinase pocket kills
catalytic activity, the mutant cannot autophosphorylate. There-
fore, the RNase remains quiescent unless the ligand 1NM-PP1
is provided to bind the excavated kinase pocket and activate
the RNase (Figure 7A). This unusual mechanism of RNase activa-
tion through allostery was previously described for yeast IRE1
(Papa et al., 2003) and appears to have been preserved through
evolution to mammals (Han et al., 2008).
A recent crystal structure model sheds light on this ligand
requirement (Lee et al., 2008). Occupancy of ADP in the yeast
IRE1 kinase active site stabilizes an ‘‘open’’ conformation,
promotes formation of an extended interface between IRE1
monomers leading to dimerization, and orients the RNase
domains for catalysis. For IRE1a (I642G), 1NM-PP1 appears to
satisfy a similar ligand function as ADP does for the WT, but
without an autophosphorylation prerequisite: working as
a ligand, 1NM-PP1 may also promote an open kinase conforma-
tion causing RNase activation.
Phosphotransfer activation of the RNase appears to occur by
an alternate mechanism. Upon induction, transgenic WT IRE1a
also spontaneously oligomerizes though the lumenal domains,
but simultaneously trans-autophosphorylates as the kinases
are juxtaposed (Figure 7B). Another recent crystal structure
shows that yeast IRE1 forms higher-order oligomers throughsalt bridges between phosphorylated activation segments of
adjacent kinase/RNases dimers (Korennykh et al., 2009). The
RNase catalytic pocket in oligomeric IRE1 is larger than that in
dimeric IRE1 and exhibits catalytic rates that are orders of
magnitude higher than that of dimers (Korennykh et al., 2009).
We speculate that these phosphorylated oligomers may be
‘‘promiscuous’’ in their RNase activity and could cause endonu-
cleolytic degradation of ER-localized mRNAs, as well as
promote XBP1 mRNA splicing; indeed, the recognized
sequences for Ins1 and Ins2 RNAs are identical to that of
XBP1 at the scission sites, but diverge at the flanks (Figure 6D).
Importantly, higher-order oligomerization of kinase/RNase
domains should not be available to IRE1a (I642G) since the
mutation kills phosphotransfer. Indeed, the in vivo Hill coefficient
of 1.8 suggests that active IRE1a (I642G) kinase/RNase splicing
units may be lower-order species that form cooperatively upon
1NM-PP1 binding—in the model, they are shown speculatively
as dimers. The RNase activity of I642G under 1NM-PP1 is never-
theless sufficient to fully splice XBP1 mRNA, which may have
evolved structural and/or ER targeting features that make it
a highly efficient substrate (Aragon et al., 2009). Other mutants
that abrogate phosphotransfer, such as I642A, or that cannot
be phosphorylated on the activation segment, also cause signif-
icant XBP1 mRNA splicing when oligomerized (Figure 2A, lane 6)
but do not promote mRNA decay or apoptosis (data not shown).
These results suggest that autophosphorylation may be formally
unnecessary for low-level XBP1 mRNA splicing; IRE1a auto-
phosphorylation during high ER stress increases RNase activity,
but may increase the risk of promoting ER mRNA decay as
higher-order oligomers form.
New approaches are needed to intervene in the apoptotic
process to treat ER stress-related diseases. Here, we showed
that kinase inhibitors can uncouple IRE1a-productive XBP1
mRNA splicing from destructive endonucleolytic events, and
this may have important therapeutic ramifications. We followed
proof of concept with 1NM-PP1 with preliminary demonstrations
that other kinase inhibitors of endogenous IRE1a can reduce
insulin mRNA decay in vivo during ER stress. We designate
such small molecules kinase-inhibiting RNase attenuators—
‘‘KIRAs.’’ KIRAs may temper RNase-mediated ER mRNA decay
by reducing IRE1a kinase/RNase oligomerization, while permit-
ting (or even enhancing) XBP1 mRNA splicing because they still
satisfy the ligand requirement (Figure 7C).
Recent provocative reports show that several FDA-approved
kinase inhibitors used to treat cancer also reverse type 1 dia-
betes in rodents (Louvet et al., 2008). Because of the plethora
of structurally related kinases, many kinase inhibitors have(D) Genes that are significantly downregulated at 6 hr under 1 mM Tg in INS-1 CAT cells. Expression changes for these genes at 2 and 4 hr under 1 mM Tg are
displayed in the same row (q value < 0.05).
(E) Genes that are significantly reduced 2-fold or more under 1 mM Tg in Ire1a+/+ MEFs (q value < 0.05), and significantly different between 1 mM Tg-treated WT
MEFs (versus untreated) and 1 mM Tg-treated Ire1a/ MEFs (versus untreated) (q value < 0.05).
(F) Genes that are significantly reduced in normally growing Ins2 (C96Y) Akita cells compared to isogenic WT controls (q value < 0.05). Annotation keys were used
to divide the predicted function of downregulated genes into SPR (secretory-pathway ER-resident protein), SPC (secretory-pathway client protein; cargo), or NSP
(nonsecretory pathway protein).
A set of IRE1a-dependent decreasing mRNAs encoding nuclear localized genes was noted (E). Color bars indicate upregulated genes in red, and downregulated
genes in green (log2). For all experiments, the mean of three or four independent biological samples is shown. See Tables S1–S6 for gene identities, log2 expres-
sion changes, and statistics.Cell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc. 571
Figure 5. Validation of Cargo and Chaperone mRNA/Protein Decay under IRE1a Phosphotransfer Activation or ER Stress
(A) Time course analysis of Ins1 mRNA expression (normalized to GAPDH) during ER stress (1 mM Tg), WT IRE1a, I642G, or N906A activation in INS-1 cells by
quantitative real-time PCR (Q-PCR).
(B) Immunoblot of proinsulin during ER stress (1 mM Tg), WT IRE1a, I642G, or N906A activation in INS-1 cells.
(C) Time course Q-PCR analysis of levels of mRNAs encoding ER-resident activities—Pdia4, Gyltl1b, Rtn4, Galnt2—during WT IRE1a, I642G, or N906A activation
in INS-1 cells.
(D) Time course Q-PCR analysis of BiP or Gyltl1b mRNA levels during ER stress (1 mM Tg). For transcription attenuation, cells were pretreated with 5 mg/mL Acti-
nomycin D (or DMSO) for 1 hr and then further treated for the indicated times with 1 mM Tg.
(E) Anti-IRE1a immunoblot of INS-1 CAT cells electroporated with IRE1a siRNA or scramble siRNA control (SCR). Q-PCR of BiP or Ins1 mRNA levels during ER
stress (1 mM Tg) in INS-1 CAT cells treated with IRE1a or SCR siRNA.
(F) Baseline XBP1 mRNA splicing in Akita and isogenic WT cells (ct14). Q-PCR analysis of Ins1 or ERdj5 mRNA levels in Akita and ct14 cells. Immunoblot analysis
of ERdj5 and proinsulin in Akita and ct14 cells is shown. Also shown is Annexin V-positive staining in Akita and ct14 cells.
Three independent biological samples were used for Q-PCR and XBP1 splicing experiments. Data are shown as mean ±SD. **p < 0.02 and ***p < 0.005.572 Cell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc.
Figure 6. Reconstitution of Insulin RNA Cleavage by IRE1a In Vitro
(A) In vitro cleavage of a 352 nt XBP1 RNA encompassing the 26 nt intron, and a full-length 503 nt mouse Ins2 RNA by immunoprecipitated (IP) WT IRE1a and
I642G proteins from T-REx 293 cells. f, substrate alone; CAT, mock IP from T-REx 293 CAT cells.
(B) Control reactions with the kinase-active/RNase-dead IRE1a (N906A). Anti-Myc immunoblot analysis shows amounts of immunoprecipitated proteins used for
in vitro cleavage reactions.
(C) In vitro cleavage of 50FAM-30BHQ-labeled XBP1 single stem-loop minisubstrate by WT IRE1a or I642G proteins ±1NM-PP1. f, substrate alone; CAT, mock IP
from T-REx 293 CAT cells.
(D) Mapping of IRE1a cleavage sites in mouse Ins2 RNA, and sequence alignment with the cleavage sites of mouse XBP1 and rat Ins1 shows conservation. An
asterisk (*) indicates complete nucleotide conservation, whereas a dot (d) indicates four out of five conserved nucleotides. Figure S13 shows cleavage site
mapping of rat Ins1 RNA.effects not confined to intended targets. It remains to be deter-
mined whether antidiabetic effects of these agents, which have
modest activity against IRE1a, are due in part to ‘‘off-target’’
KIRA effects in b cells. In turn, off-target IRE1a KIRA activitymay hamper chemotherapeutic effects, not necessarily because
homeostatic XBP1 splicing is increased, but because apoptotic
RNase-mediated mRNA decay is reduced. The development
of selective and potent KIRAs will provide the necessary toolsCell 138, 562–575, August 7, 2009 ª2009 Elsevier Inc. 573
to further investigate the therapeutic potential of this mode of
enzyme modulation.
EXPERIMENTAL PROCEDURES
Creation of Stable Cell Lines
INS-1/FRT/TO cells (#5-3.19) (Thomas et al., 2004) were grown in RPMI, 10%
fetal calf serum, 1 mM sodium pyruvate, 10 mM HEPES, 2 mM glutamine,
Figure 7. Model for Divergent IRE1a RNase
Outputs and Their Modulation by Kinase
Inhibitors
(A and B) Pseudokinase IRE1a activation (A).
Conditional overexpression of transgenic IRE1a
(I642G) causes it to cluster in the ER, allowing
1NM-PP1 to allosterically activate the RNase
when it binds the engineered kinase pocket. While
these two steps are depicted as separable,
when provided 1NM-PP1 during IRE1a (I642G)
induction, XBP1 mRNA splicing occurs identically
to that during induction of transgenic WT IRE1a—
the phosphotransfer activation mode (B). Oligo-
merization of the kinase/RNase domains in
phosphorylated IRE1a is depicted as higher order
than in IRE1a (I642G) under 1NM-PP1. Relaxed
specificity of the RNase pocket in phosphorylated
IRE1a promotes ER-localized mRNA decay during
unremediable ER stress. IRE1a (I642G) under
1NM-PP1 is maintained an alternate conformation
that restricts activity to XBP1 splicing, thus avert-
ing ER mRNA decay (A).
(C) Kinase-inhibiting RNase attenuators of IRE1a
(KIRAs). KIRAs reduce IRE1a autophosphoryla-
tion, thus reducing kinase/RNase oligomerization
and tempering ER-localized mRNA decay; KIRAs
permit, and even enhance, XBP1 mRNA splicing
because they satisfy the adenosine nucleotide
ligand requirement in endogenous IRE1a.
50 mM beta-mercaptoethanol, and 10 mg/ml blas-
ticidin. Cells were grown in 200 mg/ml zeocin and
then cotransfected with 1 mg pcDNA5/FRT/
TO::IRE1a constructs and 1 mg FLP recombinase
(pOG44) with Lipofectamine (Invitrogen). Four
hours later, cells were switched to zeocin-free
media, trypsinized 48 hr later, and then plated in
media containing hygromycin (150 mg/ml), which
was replaced every 3 days until colonies ap-
peared. IRE1a expression vectors were similarly
integrated in Flp-In T-REx 293 cells (Invitrogen).
Microarray Analysis
RNA was harvested with Trizol and quantified by
Nanodrop, and integrity was verified by Bioana-
lyzer. Fifteen micrograms of RNA was used to
synthesize cDNAs, which were purified (QIAGEN
MinElute Purification Kit) and coupled to Cy3 or
Cy5 (Amersham). See the Supplemental Experi-
mental Procedures for details of array-specific
protocols and statistical analysis.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experi-
mental Procedures, 15 figures, six tables, and
four movies and can be found with this article online at http://www.cell.com/
supplemental/S0092-8674(09)00892-7.
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